Interestingly, PI3K/Akt signaling hyperactivation occurs in approximately 45% of GBM patients.157 Inhibiting the PI3K/Akt signaling pathway can inhibit glioblastoma growth. This evidence concerns the gene AKT1 and glioblastoma.